Scinai Immunotherapeutics Ltd.
SCNINASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $1.02M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.44$5.15
- Volume (live)
- -
- Avg. volume (3M)
- 4.39M
Scinai Immunotherapeutics (SCNI) Stock Price & Financial Analysis
Scinai Immunotherapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.73 - $0.90 |
|---|---|
| 52-Week High | $5.15 |
| 52-Week Low | $0.44 |
| Open | $0.83 |
| Volume (last close) | 218.50K |
| Average Volume (3M) | 4.39M |
| Revenue (TTM) | 1.49M |
|---|---|
| Net Income (TTM) | -5.00K |
| Free Cash Flow (TTM) | -7.50M |
| EPS (TTM) | $0.00 |
| Profit Margin | -0.34% |
| Operating Margin | -403.16% |
| Return on Equity (ROE) | -0.04% |
| Debt to Equity | 0.06 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 1.02M |
|---|---|
| Shares Outstanding | 1.13M |
| Price to Sales (P/S) | 0.69 |
| Price to Book (P/B) | 0.09 |
| EV/EBITDA | 0.15 |
| 50-Day MA | $1.98 |
|---|---|
| 200-Day MA | $1.66 |
| 1-Year Change | −35.61% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Scinai Immunotherapeutics at a Glance
As of the Oct 16, 2026 close, Scinai Immunotherapeutics (SCNI) has a market capitalization of $1.02M. The stock trades at 0.7× sales. Over the trailing twelve months it lost $5.00K on revenue of $1.49M and burned $7.50M of free cash flow. Revenue grew 3.3% year over year.
As of its latest reported balance sheet, it holds $2.65M in cash and securities against $654.00K of debt, a net cash position of $2.00M.
Scinai Immunotherapeutics does not currently pay a dividend.
The share price is down 35.6% over the past year. At $0.75 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $0.44 to $5.15, below its 200-day moving average of $1.66.
Frequently Asked Questions About Scinai Immunotherapeutics
What is the current stock price for SCNI?
As of the Oct 16, 2026 close, SCNI stock trades at $0.75. The 52-week range is $0.44–$5.15, with a day range of $0.73–$0.90.
What is the P/E ratio for SCNI?
The P/E ratio (Price-to-Earnings) for SCNI is shown in the Key Statistics section. This valuation metric helps compare Scinai Immunotherapeutics Ltd. to industry peers.
Does SCNI pay dividends?
Scinai Immunotherapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for SCNI?
Analyst ratings and recommendations for SCNI are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of SCNI?
As of the Oct 16, 2026 close, Scinai Immunotherapeutics's market capitalization is $850,835.74, classifying it as a micro-cap company. Scinai Immunotherapeutics operates in the Healthcare sector within the Biotechnology industry.